If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,255.00
Bid: 2,220.00
Ask: 2,290.00
Change: -60.00 (-2.61%)
Spread: 70.00 (3.153%)
Open: 2,295.00
High: 2,240.00
Low: 2,240.00
Prev. Close: 2,300.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

16 Nov 2023 07:00

RNS Number : 6203T
Craneware plc
16 November 2023
 

 

16 November 2023

 

Craneware plc

?

("Craneware" or the "Company" or the "Group")

 

AGM Statement

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting, which takes place at 10am today.  

 

The Group has enjoyed continued positive financial and operational performance since the start of the new financial year. The partner opportunities which launched at the end of the last financial year continue to gather momentum and the underlying sales pipeline continues to build, converting at an encouraging rate into revenue. With financial results tracking in line with management expectations, we look forward to providing a greater level of detail with our next Trading Update, ahead of our Interim Results.

 

US hospitals are now returning their attention to providing Value-Based Care and building resilience into their operating models through greater insights into their financials and operations. Through Trisus, our cloud-based data analytics and intelligence platform, we plan to be a central player in the digitalisation, the use of data to provide insights that improve the processes, of US healthcare. The team is focused on capturing this opportunity through market expansion and the delivery of increased value to our extensive hospital customer base.

 

We are confident that our resilient business model, extensive customer base, high levels of Annual Recurring Revenue, together with our strategy for delivering growth centred on the expansion of the Trisus platform, will enable us to create further long-term value for all our stakeholders.   

 

For further information, please contact:

 

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon

craneware@almastrategic.com

 

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers

 

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

  

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDBBDBCXBDGXU
Date   Source Headline
7th Jul 20226:13 pmRNSHolding(s) in Company
27th Apr 20221:00 pmRNSBoard Appointment
14th Apr 202212:35 pmRNSBlock listing Interim Review
31st Mar 20224:09 pmRNSTotal Voting Rights
25th Mar 20222:16 pmRNSDividend Currency Election
22nd Mar 20221:37 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Payment Date Update
14th Mar 20227:00 amRNSInterim Results
7th Mar 20225:20 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSBlocklisting Application
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSTrading Update and Notice of Results
26th Nov 20215:05 pmRNSDividend Currency Election
19th Nov 20212:46 pmRNSGrant of Long Term Incentive Plan Awards
16th Nov 20212:09 pmRNSResult of AGM
16th Nov 20217:00 amRNSAGM Statement and Integration Update
19th Oct 20217:00 amRNSPosting of Annual Report and Notice of AGM
15th Oct 20213:37 pmRNSBlock listing Interim Review
22nd Sep 202112:52 pmRNSPurchase of Shares
21st Sep 20215:58 pmRNSDividend Timetable
21st Sep 20217:00 amRNSFinal Results
20th Jul 20214:53 pmRNSHolding(s) in Company
14th Jul 20215:19 pmRNSHolding(s) in Company
13th Jul 20217:00 amRNSCompletion of SDS Holdco, Inc. Acquisition
13th Jul 20217:00 amRNSTrading Update and Notice of Results
18th Jun 202111:42 amRNSHolding(s) in Company
14th Jun 202110:01 amRNSHolding(s) in Company
10th Jun 202111:55 amRNSHolding(s) in Company
10th Jun 202111:53 amRNSDirector/PDMR Share Dealings
8th Jun 20214:40 pmRNSSecond Price Monitoring Extn
8th Jun 20214:35 pmRNSPrice Monitoring Extension
8th Jun 20212:05 pmRNSSecond Price Monitoring Extn
8th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 202111:05 amRNSSecond Price Monitoring Extn
8th Jun 202111:00 amRNSPrice Monitoring Extension
8th Jun 20219:05 amRNSSecond Price Monitoring Extn
8th Jun 20219:00 amRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSResults of Placing and Total Voting Rights
7th Jun 20215:27 pmRNSProposed Placing
7th Jun 20215:25 pmRNSAcquisition of SDS Holdco, Inc.
15th Apr 20217:00 amRNSBlock listing Interim Review
19th Mar 20211:05 pmRNSDividend Currency Election
1st Mar 20217:00 amRNSInterim Results
20th Jan 20217:00 amRNSTrading Update and Notice of Results
7th Dec 20201:11 pmRNSHolding(s) in Company
1st Dec 20201:22 pmRNSHolding(s) in Company
26th Nov 20207:00 amRNSAppointment of Joint Broker
20th Nov 20205:49 pmRNSDividend Currency Election
17th Nov 20201:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.